Cargando…
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of indeterminate potential (CHIP) has emerged as a risk factor for chronic i...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409316/ https://www.ncbi.nlm.nih.gov/pubmed/32708264 http://dx.doi.org/10.3390/cancers12071992 |
_version_ | 1783568038286589952 |
---|---|
author | Duployez, Nicolas Demonchy, Jordane Berthon, Céline Goutay, Julien Caplan, Morgan Moreau, Anne-Sophie Bignon, Anne Marceau-Renaut, Alice Garrigue, Delphine Raczkiewicz, Imelda Geffroy, Sandrine Bucci, Maxime Alidjinou, Kazali Demaret, Julie Labalette, Myriam Brousseau, Thierry Dupont, Annabelle Rauch, Antoine Poissy, Julien Susen, Sophie Preudhomme, Claude Quesnel, Bruno |
author_facet | Duployez, Nicolas Demonchy, Jordane Berthon, Céline Goutay, Julien Caplan, Morgan Moreau, Anne-Sophie Bignon, Anne Marceau-Renaut, Alice Garrigue, Delphine Raczkiewicz, Imelda Geffroy, Sandrine Bucci, Maxime Alidjinou, Kazali Demaret, Julie Labalette, Myriam Brousseau, Thierry Dupont, Annabelle Rauch, Antoine Poissy, Julien Susen, Sophie Preudhomme, Claude Quesnel, Bruno |
author_sort | Duployez, Nicolas |
collection | PubMed |
description | Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of indeterminate potential (CHIP) has emerged as a risk factor for chronic inflammatory background and subsequent aging-associated diseases. The purpose of this study was to identify biological factors (particularly leukocyte subtypes and inflammatory markers) associated with a risk of clinical deterioration (i.e., orotracheal intubation (OTI)) and to determine whether CH was likely to influence clinical and biological behavior in patients with severe COVID-19 requiring hospitalization. Here, we describe clinical and biological features, including the screening of CHIP mutants in a well-annotated cohort of 122 hospitalized patients with a laboratory-confirmed diagnosis of COVID-19 (55% requiring OTI). We showed that elevated white blood cell counts, especially neutrophils and high C-reactive protein (CRP) levels at admission, were associated with an increased requirement of OTI. We noticed a high prevalence of CH (25%, 38%, 56%, and 82% of patients aged <60 years, 60–70 years, 70–80 years, and >80 years) compared to a retrospective cohort of patients free of hematological malignancy explored with the same pipelines (10%, 21%, 37%, and 44%). However, the existence of CH did not significantly impact clinical outcome, including OTI or death, and did not correlate with other laboratory findings. |
format | Online Article Text |
id | pubmed-7409316 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-74093162020-08-25 Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 Duployez, Nicolas Demonchy, Jordane Berthon, Céline Goutay, Julien Caplan, Morgan Moreau, Anne-Sophie Bignon, Anne Marceau-Renaut, Alice Garrigue, Delphine Raczkiewicz, Imelda Geffroy, Sandrine Bucci, Maxime Alidjinou, Kazali Demaret, Julie Labalette, Myriam Brousseau, Thierry Dupont, Annabelle Rauch, Antoine Poissy, Julien Susen, Sophie Preudhomme, Claude Quesnel, Bruno Cancers (Basel) Article Advanced age or preexisting comorbidities have been characterized as risk factors for severe coronavirus disease 2019 (COVID-19) cases requiring hospitalization and intensive care. In recent years, clonal hematopoiesis (CH) of indeterminate potential (CHIP) has emerged as a risk factor for chronic inflammatory background and subsequent aging-associated diseases. The purpose of this study was to identify biological factors (particularly leukocyte subtypes and inflammatory markers) associated with a risk of clinical deterioration (i.e., orotracheal intubation (OTI)) and to determine whether CH was likely to influence clinical and biological behavior in patients with severe COVID-19 requiring hospitalization. Here, we describe clinical and biological features, including the screening of CHIP mutants in a well-annotated cohort of 122 hospitalized patients with a laboratory-confirmed diagnosis of COVID-19 (55% requiring OTI). We showed that elevated white blood cell counts, especially neutrophils and high C-reactive protein (CRP) levels at admission, were associated with an increased requirement of OTI. We noticed a high prevalence of CH (25%, 38%, 56%, and 82% of patients aged <60 years, 60–70 years, 70–80 years, and >80 years) compared to a retrospective cohort of patients free of hematological malignancy explored with the same pipelines (10%, 21%, 37%, and 44%). However, the existence of CH did not significantly impact clinical outcome, including OTI or death, and did not correlate with other laboratory findings. MDPI 2020-07-21 /pmc/articles/PMC7409316/ /pubmed/32708264 http://dx.doi.org/10.3390/cancers12071992 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Duployez, Nicolas Demonchy, Jordane Berthon, Céline Goutay, Julien Caplan, Morgan Moreau, Anne-Sophie Bignon, Anne Marceau-Renaut, Alice Garrigue, Delphine Raczkiewicz, Imelda Geffroy, Sandrine Bucci, Maxime Alidjinou, Kazali Demaret, Julie Labalette, Myriam Brousseau, Thierry Dupont, Annabelle Rauch, Antoine Poissy, Julien Susen, Sophie Preudhomme, Claude Quesnel, Bruno Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 |
title | Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 |
title_full | Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 |
title_fullStr | Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 |
title_full_unstemmed | Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 |
title_short | Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19 |
title_sort | clinico-biological features and clonal hematopoiesis in patients with severe covid-19 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409316/ https://www.ncbi.nlm.nih.gov/pubmed/32708264 http://dx.doi.org/10.3390/cancers12071992 |
work_keys_str_mv | AT duployeznicolas clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT demonchyjordane clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT berthonceline clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT goutayjulien clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT caplanmorgan clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT moreauannesophie clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT bignonanne clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT marceaurenautalice clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT garriguedelphine clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT raczkiewiczimelda clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT geffroysandrine clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT buccimaxime clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT alidjinoukazali clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT demaretjulie clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT labalettemyriam clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT brousseauthierry clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT dupontannabelle clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT rauchantoine clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT poissyjulien clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT susensophie clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT preudhommeclaude clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT quesnelbruno clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 AT clinicobiologicalfeaturesandclonalhematopoiesisinpatientswithseverecovid19 |